US Halts Astra Covid Vaccine Production After J&J Confusion, NYT Says

Workers inside a lab at Emergent Biosolutions in Baltimore on February 8.

Michael Robinson Chavez / The Washington Post / Getty Images

The U.S. Department of Health and Human Services on Saturday stopped a Baltimore manufacturer from making AstraZeneca Plc’s Covid-19 vaccine, days after the facility screwed up 15 million doses of injections developed by Johnson & Johnson, The New York Times reported, citing two top federal health officials. they were not identified.

The move came after Maryland-based biotech company Emergent BioSolutions Inc. accidentally mixed the ingredients of the two vaccines, forcing regulators to delay approval of the plant’s production, the newspaper said. .

The department also asked Johnson & Johnson to install a new team to oversee all aspects of manufacturing at the facility, the newspaper said, citing officials. The company confirmed the changes and was “assuming full responsibility,” NYT said.

AstraZeneca will work with the Biden administration to find an alternative site, the newspaper said, citing the drugmaker.

NOTE: J&J vaccine manufacturing error affects 15 million doses


Source link